Inactive Instrument

News Cornerstone Therapeutics, Inc.

Stocks

US21924P1030

Pharmaceuticals

End-of-day quote Nasdaq
- ^USD	-

All News

Mentions Relevance

14-02-28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
14-02-03	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
14-01-31	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
13-11-20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
13-10-31	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU
13-09-24	Cornerstone Therapeutics, Inc. : Law Firm Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Cornerstone Therapeutics, Inc. in Connection With a Proposed Buyout	BU
13-09-16	Cornerstone Therapeutics, Inc. : Rigrodsky & Long, P.A. Announces Investigation Of Cornerstone Therapeutics, Inc. Buyout	BU
13-09-16	Cornerstone Therapeutics, Inc. : Shareholder Rights Law Firm Johnson & Weaver, LLP, is Investigating the Cornerstone Buyout	BU
13-09-16	Cornerstone Therapeutics, Inc. : Law Firm Brower Piven Announces Investigation of Cornerstone Therapeutics, Inc. Proposed Acquisition	BU
13-09-16	Cornerstone Therapeutics, Inc. : Finkelstein Thompson LLP Announces Investigation of Cornerstone Therapeutics Inc. Buyout	BU
13-09-16	Cornerstone Therapeutics, Inc. : Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 per Share in Cash	PU
13-09-03	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Reports First Quarter 2013 Financial Results	PU
13-08-03	Cornerstone Therapeutics, Inc. : REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call	PU
13-07-24	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Sues to Enforce Its CARDENE(R) I.V. Patents	PU
13-06-30	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2012 Conference Call	PU
13-06-13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter	PU
13-02-25	Cornerstone Therapeutics, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders	BU
12-05-14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Acquire EKR Therapeutics, Accelerating Expansion in Hospital Market	PU
12-03-13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Receives FDA Acceptance for CRTX 080 NDA for Treatment of Hyponatremia	PU
11-09-12	CORNERSTONE THERAP : New Research Indicates Treating Neonatal Respiratory Distress Syndrome with CUROSURF® Results in Lower Rate of Mortality Compared to Competitive Surfactants	BU
11-02-18	CORNERSTONE THERAP : Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call	PR
10-10-28	CORNERSTONE THERAP : Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call	PR
10-09-08	CORNERSTONE THERAP : Cornerstone Therapeutics to Present at Rodman & Renshaw 12th Annual Healthcare Conference	PR
10-08-05	CORNERSTONE THERAP : Cornerstone Therapeutics Announces Development of Generic for Tussionex®	PR
10-08-05	CORNERSTONE THERAP : Cornerstone Therapeutics Reports Second Quarter 2010 Financial Results	PR